InvestorsHub Logo
Followers 467
Posts 26906
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 16

Thursday, 06/23/2011 8:56:18 AM

Thursday, June 23, 2011 8:56:18 AM

Post# of 62
7. Theravance Inc. (THRX): Biotechnology Industry. Market cap of $1.86B. Current price at $21.99 vs. target price of $27.8 (implies a potential upside of 26.42%). Net insiders purchases over the last 6 months is 5.19M shares, which represents 9.92% of the 52.32M share float. The stock is a short squeeze candidate, with a short float at 8.61% (equivalent to 14.23 days of average volume). The stock has performed poorly over the last month, losing 13.19%.

http://seekingalpha.com/article/276281-10-undervalued-biotech-stocks-with-insider-buying?source=yahoo


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THRX News